Veradermics, Incorporated · NYSE:MANE
Citadel Advisors LLC's stake in Veradermics, Incorporated fell to 4.50% (Schedule 13G)
Event Apr 30, 2026 · Filed May 7, 2026
Citadel Advisors LLC's stake in Veradermics, Incorporated fell to 4.50%, 1,870,775 shares, as a passive investor on Apr 30, 2026. Filed May 7, 2026 (Schedule 13G).
- Stake
- 4.50%
- Shares
- 1,870,775
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 4.50% | 1,870,775 |
| Citadel Advisors Holdings LP | 4.50% | 1,870,775 |
| Citadel GP LLC | 4.50% | 1,870,775 |
| Citadel Securities LLC | 0% | 17 |
| Citadel Securities Group LP | 0% | 17 |
| Citadel Securities GP LLC | 0% | 17 |
| Kenneth Griffin | 4.50% | 1,870,792 |
Source
Related
- Veradermics, Incorporated
- Citadel Advisors LLC
- Veradermics, Incorporated shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Hollander David · Sep 3, 2026
- Form 4 · Averill Master Fund, Ltd. · Aug 21, 2026
- Schedule 13D/A · Montanova Capital, LLC · Aug 21, 2026
- Form 4 · Durso Timothy August · Aug 18, 2026